GLP1R and type 2 diabetes mellitus: Kristensen Kristensen SL SL Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials Lancet Diabetes Endocrinol Lancet Diabetes Endocrinol 2019 2019 7 7 10 10 776 776 785 785 10.1016/S2213-8587(19)30249-9 10.1016/S2213-8587(19)30249-9 supplied-pmid 31422062?